Analysis of A Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Compound Heterozygous Mutations.
10.19746/j.cnki.issn.1009-2137.2022.02.042
- Author:
Jing CHEN
1
;
Yun-Xia LI
1
;
Fan ZHONG
1
;
Ren-Hua LI
1
;
Ji-Yun YANG
2
;
Wen-Jing ZHOU
3
Author Information
1. Department of Laboratory Medicine, Xindu District People's Hospital, Chengdu 610500, Sichuan Province, China.
2. Sichuan Provincial Key Laboratory for Human Disease Gene Study, Affiliated Hospital of the University of Electronic Science and Technology, Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan Province, China,Prenatal Diagnosis Center, Affiliated Hospital of the University of Electronic Science and Technology, Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan Province, China,E-mail：yangjiyun@yeah.net.
3. Sichuan Provincial Key Laboratory for Human Disease Gene Study, Affiliated Hospital of the University of Electronic Science and Technology, Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan Province, China,Prenatal Diagnosis Center, Affiliated Hospital of the University of Electronic Science and Technology, Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan Province, China,E-mail：tiantian-0628@163.com.
- Publication Type:Journal Article
- Keywords:
F12 gene;
coagulation factor Ⅻ deficiency;
novel mutation
- MeSH:
Blood Coagulation Disorders;
Codon, Nonsense;
Factor XII/genetics*;
Female;
Heterozygote;
Humans;
Male;
Mutation;
Pedigree
- From:
Journal of Experimental Hematology
2022;30(2):571-576
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analysis clinical phenotype and potential genetic cause of a family affected with hereditary coagulation factor Ⅻ deficiency.
METHODS:The prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), D-Dimer (D-D), coagulation factor Ⅻ activity (FⅫ:C) and coagulation factor Ⅻ antigen (FⅫ:Ag) were determined for phenotype diagnosis of the proband and his family members(3 generations and 5 people). Targeted capture and whole exome sequencing were performed in peripheral blood sample of the proband. Possible disease-causing mutations of F12 gene were obtained and further confirmed by Sanger sequencing. The corresponding mutation sites of the family members were analyzed afterwards. The online bioinformatics software AutoPVS1 and Mutation Taster was used to predict the effects of mutation sites on protein function.
RESULTS:The APTT of the proband was significantly prolonged, reaching 180.9s. FⅫ:C and FⅫ:Ag of the proband was significantly reduced to 0.8% and 4.17%, respectively. The results of whole exome sequencing displayed that there were compound heterozygous mutations in F12 gene of the proband, including the c.1261G＞T heterozygous nonsense mutation in exon 11 (causing p.Glu421*) and the c.251dupG heterozygous frameshift mutation in exon 4 (causing p.Trp85Metfs*53). Both mutations are loss of function mutations with very strong pathogenicity, leading to premature termination of the protein. AutoPVS1 and Mutation Taster software predicted both mutations as pathogenic mutations. The results of Sanger sequencing revealed that c.1261G＞T heterozygous mutation of the proband was inherited from his mother, for which his brother and his daughter were c.1261G＞T heterozygous carriers. Genotype-phenotype cosegregation was observed in this family.
CONCLUSION:The c.1261G＞T heterozygous nonsense mutation in exon 11 and the c.251dupG heterozygous frameshift mutation in exon 4 of the F12 gene probably account for coagulation factor Ⅻ deficiency in this family. This study reports two novel pathogenic F12 mutations for the first time worldwide.
